FDA mulls subjecting metal hip implants to tougher oversight

01/18/2013 | Reuters · Wall Street Journal, The

The FDA has proposed requiring makers of metal-on-metal hip implants to submit additional data to back the safety and effectiveness of their devices in order to continue marketing them. The move is spurred by concerns that the devices can lead to soft-tissue damage and may require replacement surgery.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ